Anlotinib with Camrelizumab in Lung Cancer Treatment

Anlotinib with Camrelizumab in Lung Cancer Treatment Background Checkpoint inhibitors (CPIs) and anti-angiogenic agents are emerging as potential novel treatment choices for advanced cancers including metastatic non-small-cell lung cancer (NSCLC). However, the combination of these two standard therapies has not been investigated in third-line or further-line treatment of patients with advanced NSCLC.

Diffuse-Type Tenosynovial Giant Cell Tumors: Treatments and Progression

Diffuse-Type Tenosynovial Giant Cell Tumors: Treatments and Progression Tenosynovial giant cell tumors (TGCT) - An Introduction Tenosynovial giant cell tumors (TGCT) are rare, locally invasive lesions of synovial origin that involve joints, tendon sheaths, and bursae.  TGCT may be intra- or extra-articular and is classified by growth pattern and clinical presentation as

Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report

Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report Overview  A male patient, 52 years of age, underwent pneumonectomy of the left lung. He was previously diagnosed with primary spindle cell carcinoma (pT4aN1M0, stage III B) with programmed death-ligand 1 expression (tumor proportion score ≥95%) and without epidermal growth factor

Breast Tomosynthesis Simulator for Virtual Clinical Trials

Breast Tomosynthesis Simulator for Virtual Clinical Trials Summary  The use of computer models and simulation in predicting the clinical performance of x-ray imaging devices in silico and generating synthetic patient images for training and testing of machine learning algorithms is widely accepted today.  In this study, the researchers presented a detailed description of

Renal Cell Carcinoma- Prognosis via Albumin Levels

Renal Cell Carcinoma- Prognosis via Albumin Levels Metastatic renal cell carcinoma (mRCC) - An Introduction Renal cell carcinoma (RCC) constitutes approximately 90% of all urologic malignancies. Approximately 30% of patients with RCC present with metastatic disease, and amongst those with localized disease, a substantial proportion will recur. Before 2005, immunotherapy with interleukin-2

Diagnostic Error Causing Cases of Cytopenia

Diagnostic Error Causing Cases of Cytopenia Summary  Many psychotropic drugs are known to cause cytopenia after increasing dosage or during the beginning of treatment. Cytopenia can also be caused by other conditions such as leukemia. These two case reports report on cases of cytopenia which happened during adjustment of psychotropic mediations in

Thymoma Case Report: Entire-Tumor Calcification

Thymoma Case Report: Entire-Tumor Calcification Background Thymoma is a type of anterior mediastinal tumor that is quite common. It represents around 50% of anterior mediastinal masses and around 20-30% of all types of mediastinal tumors. Thymomas are hard to distinguish between invasive or encapsulated types. Thymomas often affects patients in their middle ages.

Sugammadex versus Neostigmine in Thyroidectomy

Sugammadex versus Neostigmine in Thyroidectomy Today, many operations require changes in the level of intraoperative neuromuscular blockade. Historically, the drug neostigmine has been used to reverse the neuromuscular blockade, even if it was risky and the speed of reversal was unsatisfactory. There are also several related problems caused by neostigmine including

Anlotinib with Camrelizumab in Lung Cancer Treatment